EORTC protocol 11001

10B-uptake in different tumours using the boron compounds BSH and BPA.
Trial StatusAll trial activities ended
DatesDate of activation: 29-Apr-03
Data management at EORTCFull
Phase1
Randomized trialNo
Type-
Targeted Sample size27
Number of steps1
DrugPara-boronophenylalanine
Sodium mercaptoundecahydro-closo-dodecaborate
Study StaffWolfgang Sauerwein (Study Coordinator) - Universitaetsklinikum - Essen, Essen
Laurence Collette (Statistician) - EORTC Headquarters, Brussels
Catherine Hermans (Data Manager) - EORTC Headquarters, Brussels
Type of cancerLiver
Thyroid
Head and Neck
Participating GroupsEORTC Boron Neutron Capture Therapy Group (closed group)(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00062348
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
Back to Protocol section